Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalifa

Showing results (621-630 of 641) with videos related to

Pageof 65
Sort By:
Nature|December 9, 2021
Malaria protection due to sickle haemoglobin depends on parasite genotypeGavin Band, Ellen M Leffler, Muminatou Jallow, et al.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
NPJ Vaccines|February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases|August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trialAlassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
Plos Genetics|May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populationsGavin Band, Quang Si Le, Luke Jostins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2016
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and InfantsMuhammed O Afolabi, Alfred B Tiono, Uche J Adetifa, et al.
Plos Medicine|January 13, 2016
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialPeter G Kremsner, Akim A Adegnika, Aurore B Hounkpatin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and InfantsCarly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trialLorenz von Seidlein, Rasaq Olaosebikan, Ilse C E Hendriksen, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Pageof 65

Showing results (621-630 of 641) with videos related to

Sort By:
Pageof 65
Nature|December 9, 2021
Malaria protection due to sickle haemoglobin depends on parasite genotypeGavin Band, Ellen M Leffler, Muminatou Jallow, et al.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
NPJ Vaccines|February 6, 2025
The anti-circumsporozoite antibody response to repeated, seasonal booster doses of the malaria vaccine RTS,S/AS01<sub>E</sub>M Sanni Ali, Lisa Stockdale, Issaka Sagara, et al.
The Lancet. Infectious Diseases|August 25, 2023
Seasonal vaccination with RTS,S/AS01<sub>E</sub> vaccine with or without seasonal malaria chemoprevention in children up to the age of 5 years in Burkina Faso and Mali: a double-blind, randomised, controlled, phase 3 trialAlassane Dicko, Jean-Bosco Ouedraogo, Issaka Zongo, et al.
Plos Genetics|May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populationsGavin Band, Quang Si Le, Luke Jostins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2016
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and InfantsMuhammed O Afolabi, Alfred B Tiono, Uche J Adetifa, et al.
Plos Medicine|January 13, 2016
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialPeter G Kremsner, Akim A Adegnika, Aurore B Hounkpatin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and InfantsCarly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 14, 2012
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trialLorenz von Seidlein, Rasaq Olaosebikan, Ilse C E Hendriksen, et al.
Plos One|March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adultsCaroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Pageof 65